MetaCap

BioNexus Gene Lab Corp Company Profile

NASDAQ: BGLCHealth CareMedical SpecialitiesUSD

0.680.00 (0.00%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

BioNexus Gene Lab at a glance

BioNexus Gene Lab Corp (NASDAQ: BGLC) is a Medical Specialities company in the Health Care sector headquartered in Kuala Lumpur, Malaysia. BioNexus Gene Lab is led by Mr. Su-Leng Tan and employs about 19 people. At a market capitalization of $2.0 million, it is considered a small-cap company.

Its SEC Central Index Key (CIK) is 0001737523, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does BioNexus Gene Lab do?

BioNexus Gene Lab Corp., together with its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company operates through three segments: Trading of Industrial Chemicals; Provision for Genomic Screening Services; and Investment Holding. It offers various chemical raw material products, including polyester resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; polyester resin 9509, a general-purpose material used in the production of marine boats and water slides; and polyester resin 2802, which is used as a component in the pultrusion process. The company's products are used in producing various finished goods, such as handrails, bench tops, and automotive and aero parts; paneling for hospital, laboratory, and industrial clean rooms; and covers for various instruments used in manufacturing. It develops and provides non-invasive liquid biopsy tests for the early detection of biomarkers. BioNexus Gene Lab Corp. was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.

Business description based on the company's public filings.

Company information

Legal name
BioNexus Gene Lab Corp
Ticker
NASDAQ: BGLC
Industry
Medical Specialities
CEO
Mr. Su-Leng Tan
Employees
19
Headquarters
Menara UOA Bangsar, Kuala Lumpur, Malaysia
Phone
60 1 307 241 6898
SEC CIK
0001737523
Latest annual report
10-K · Apr 14, 2026

Companies similar to BioNexus Gene Lab

BGLC peer companies
CompanyPrice% ChgMarket capCompare
ADVBAdvanced Biomed Inc.1.65-5.71%$2.73Mvs BGLC
ACONAclarion Inc.1.22-13.92%$3.52Mvs BGLC
AMSAmerican Shared Hospital Services1.00-4.76%$6.67Mvs BGLC
MDXHMDxHealth SA0.1074-8.52%$10.25Mvs BGLC
SERASera Prognostics Inc. Class A1.81-4.23%$71.98Mvs BGLC
BDSXBiodesix Inc.7.56-8.92%$83.83Mvs BGLC
XGNExagen Inc.3.61-5.00%$92.10Mvs BGLC
KEQUKewaunee Scientific Corporation33.55-2.75%$97.14Mvs BGLC

Related